Other Issues

Browse Other Issues Content

CHPA’s SVP of Dietary Supplements, Duffy MacKay, responds to reporting on a recent research letter published in JAMA finding that 22 out of 25 melatonin products analyzed were mislabeled, containing variable amounts of the ingredient:

Apr 25, 2023

If you are in the consumer healthcare industry, you probably know about GMPs, or Good Manufacturing Practices. But what do they specifically mean when it comes to dietary supplements, and how do VMS companies prepare for an FDA inspection?

Apr 24, 2023

Millions of Americans rely on OTC medicines. Following the COVID-19 pandemic, OTCs have become an even more essential part of the treatment toolbox. Today, we take a look at the value created by OTC medicines as we walk through some of the top findings from CHPA's latest OTC value study.

Apr 10, 2023

Good science, and new customer behavior mean the time is right for companies to evaluate their portfolios to position themselves for success. Tailwinds are good, private equity interest is high, and the self-care future is bright.

Mar 13, 2023

The Consumer Healthcare Products Association’s (CHPA) Educational Foundation today announced the launch of HealthInHand.org

Mar 1, 2023

If you're one of the 30 million Americans experiencing hearing loss, here's some exciting news. OTC hearing aids are now available nationwide. It's a totally new way for consumers to care for their own hearing health, and an interesting look at how public health and digital technology can intersect.

Feb 27, 2023

CHPA strongly encourages FDA to provide further clarity regarding the appropriate human factors information in premarket submissions that involve a change from prescription use to over-the-counter use and associated changes from a predicate device as compared to modifications to a sponsor’s own device.

Feb 21, 2023

Filter Results